netFormulary
 Report : A-Z CDF items in Formulary 04/07/2020 04:15:31
[Back]
 
Section Status CDF Name
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone 250mg Zytiga
08.01.05 Restricted Use Cancer Drugs Fund Atezolizumab 1200mg Tecentriq
08.01.05 Restricted Use Cancer Drugs Fund Avelumab 20mg/mL Bavencio
08.01.05 Restricted Use Cancer Drugs Fund Axicabtagene ciloleucel  Yescarta
08.01.01 Restricted Use Cancer Drugs Fund Bendamustine 
02.02 Non Formulary Cancer Drugs Fund Bendroflumethiazide Bendro
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
08.01.05 Restricted Use Cancer Drugs Fund Cemiplimab  Libtayo®
08.01.03 Non Formulary Cancer Drugs Fund Clofarabine Evoltra
01.01 Non Formulary Cancer Drugs Fund Damani Ak
08.01.05 Restricted Use Cancer Drugs Fund Daratumumab 20mg/mL Darzalex
08.01.05 Restricted Use Cancer Drugs Fund Durvalumab 50 mg/ml concentrate solution for infusion Imfinzi
08.01.05 Restricted Use Cancer Drugs Fund Ibrutinib 140mg Imbruvica
08.01.05 Restricted Use Cancer Drugs Fund Ixazomib Ninlaro
08.01.05 Restricted Use Cancer Drugs Fund Larotrectinib  Vitrakvi
08.02.04 Restricted Use Cancer Drugs Fund Lenalidomide 
08.01.03 Non Formulary Cancer Drugs Fund Nelarabine Atriance
08.01.05 Restricted Use Cancer Drugs Fund Niraparib 100mg Zejula
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.05 Restricted Use Cancer Drugs Fund Pertuzumab Perjeta
08.02.04 Restricted Use Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Restricted Use Cancer Drugs Fund Ponatinib 15mg, 30mg, 45mg Iclusig
08.01.05 Restricted Use Cancer Drugs Fund Regorafenib 40mg Stivarga
08.01.05 Restricted Use Cancer Drugs Fund Rucaparib Rubraca
08.01.05 Restricted Use Cancer Drugs Fund Sorafenib 200mg Nexavar
08.01.05 Non Formulary Cancer Drugs Fund Temsirolimus Torisel
08.01.05 Restricted Use Cancer Drugs Fund Tisagenlecleucel Kymriah
08.01.05 Non Formulary Cancer Drugs Fund Vandetanib Caprelsa
08.01.05 Restricted Use Cancer Drugs Fund Vismodegib 150mg Erivedge
Bedfordshire and Luton Joint Formulary